https://www.selleckchem.com/products/i-138.html
0001, respectively) and graft loss (HR 1.58, p=.0008; HR 1.22, p=.04; HR 1.43, p=.0007, respectively). Pediatric patients who are obese at the time of HT and dyslipidemic at 1year post-HT are at an increased risk for CAV and graft loss. Preventative interventions may reduce morbidity and mortality among this cohort. Pediatric patients who are obese at the time of HT and dyslipidemic at 1 year post-HT are at an increased risk for CAV and graft loss. Preventative interventions may reduce morbidity and mortality among this cohort. To investi
Like
Comment
Share
